These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34746313)

  • 21. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
    Kaur K; Kumar P; Kush P
    Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanocarrier systems for oral drug delivery: do we really need them?
    Bernkop-Schnürch A
    Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid antisolvent precipitation: an effective method for ocular targeting of lutein esters.
    Wu M; Feng Z; Deng Y; Zhong C; Liu Y; Liu J; Zhao X; Fu Y
    Int J Nanomedicine; 2019; 14():2667-2681. PubMed ID: 31043780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is nanotechnology a boon for oral drug delivery?
    Agrawal U; Sharma R; Gupta M; Vyas SP
    Drug Discov Today; 2014 Oct; 19(10):1530-46. PubMed ID: 24786464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
    Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
    J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
    Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
    Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 32. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in liposome surface modification for oral drug delivery.
    Nguyen TX; Huang L; Gauthier M; Yang G; Wang Q
    Nanomedicine (Lond); 2016 May; 11(9):1169-85. PubMed ID: 27074098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-time oral administration of resveratrol-loaded layer-by-layer nanoparticles to rats - a pharmacokinetics study.
    Santos AC; Veiga FJ; Sequeira JAD; Fortuna A; Falcão A; Pereira I; Pattekari P; Fontes-Ribeiro C; Ribeiro AJ
    Analyst; 2019 Mar; 144(6):2062-2079. PubMed ID: 30724915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical toxicities of nanocarrier systems.
    Vega-Villa KR; Takemoto JK; Yáñez JA; Remsberg CM; Forrest ML; Davies NM
    Adv Drug Deliv Rev; 2008 May; 60(8):929-38. PubMed ID: 18313790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
    Lin CH; Chen CH; Lin ZC; Fang JY
    J Food Drug Anal; 2017 Apr; 25(2):219-234. PubMed ID: 28911663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Drug Deliv; 2016 Oct; 23(8):2990-2997. PubMed ID: 26800371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.
    Hanna LA; Basalious EB; ELGazayerly ON
    Drug Deliv; 2016 Nov; 24(1):188-198. PubMed ID: 28156176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Systematic Review of Functionalized Polymeric Nanoparticles to Improve Intestinal Permeability of Drugs and Biological Products.
    de Souza ML; de Albuquerque Wanderley Sales V; Alves LP; Dos Santos WM; de Moura Ferraz LR; de Andrade Lima GS; Dos Santos Mendes LM; Rolim LA; Neto PJR
    Curr Pharm Des; 2022; 28(5):410-426. PubMed ID: 34348618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.